BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dryer SE, Roshanravan H, Kim EY. TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease. Biochim Biophys Acta Mol Basis Dis 2019;1865:1041-66. [PMID: 30953689 DOI: 10.1016/j.bbadis.2019.04.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Feng Y, Li M, Wang Y, Yang M, Shi G, Yin D, Xuan Z, Xu F. Activation of TRPC6 by AngⅡ Induces Podocyte Injury and Participates in Proteinuria of Nephrotic Syndrome. Front Pharmacol 2022;13:915153. [DOI: 10.3389/fphar.2022.915153] [Reference Citation Analysis]
2 Kim EY, Dryer SE. TRPC6 Inactivation Reduces Albuminuria Induced by Protein Overload in Sprague Dawley Rats. Cells 2022;11:1985. [DOI: 10.3390/cells11131985] [Reference Citation Analysis]
3 Zheng Z, Xu Y, Krügel U, Schaefer M, Grune T, Nürnberg B, Köhler MB, Gollasch M, Tsvetkov D, Markó L. In Vivo Inhibition of TRPC6 by SH045 Attenuates Renal Fibrosis in a New Zealand Obese (NZO) Mouse Model of Metabolic Syndrome. Int J Mol Sci 2022;23:6870. [PMID: 35743312 DOI: 10.3390/ijms23126870] [Reference Citation Analysis]
4 Chai X, Ludwig F, Müglitz A, Gong Y, Schaefer M, Regenthal R, Krügel U. A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MS. IJMS 2022;23:3635. [DOI: 10.3390/ijms23073635] [Reference Citation Analysis]
5 Palygin O. The role of TRPC6 channel in chronic kidney disease. Am J Physiol Renal Physiol 2022. [PMID: 35037467 DOI: 10.1152/ajprenal.00455.2021] [Reference Citation Analysis]
6 Gyarmati G, Toma I, Izuhara A, Burford JL, Shroff UN, Papadouri S, Deepak S, Peti-Peterdi J. The role of TRPC6 calcium channels and P2 purinergic receptors in podocyte mechanical and metabolic sensing. Physiol Int 2021:2021. [PMID: 34978536 DOI: 10.1556/2060.2021.00205] [Reference Citation Analysis]
7 Wang Z, Fu Y, do Carmo JM, da Silva AA, Li X, Mouton AJ, Omoto ACM, Sears J, Hall JE. Transient Receptor Potential Cation Channel 6 (TRPC6) Contributes to Kidney Injury Induced by Diabetes and Hypertension. Am J Physiol Renal Physiol 2021. [PMID: 34866402 DOI: 10.1152/ajprenal.00296.2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lin B, Liu J, Zhang Y, Wu Y, Chen S, Bai Y, Liu Q, Qin X. Urinary peptidomics reveals proteases involved in idiopathic membranous nephropathy. BMC Genomics 2021;22:852. [PMID: 34819020 DOI: 10.1186/s12864-021-08155-3] [Reference Citation Analysis]
9 Yang PL, Li XH, Wang J, Ma XF, Zhou BY, Jiao YF, Wang WH, Cao P, Zhu MX, Li PW, Xiao ZH, Li CZ, Guo CR, Lei YT, Yu Y. GSK1702934A and M085 directly activate TRPC6 via a mechanism of stimulating the extracellular cavity formed by the pore helix and transmembrane helix S6. J Biol Chem 2021;297:101125. [PMID: 34461094 DOI: 10.1016/j.jbc.2021.101125] [Reference Citation Analysis]
10 Armelloni S, Mattinzoli D, Ikehata M, Alfieri C, Belingheri M, Moroni G, Cresseri D, Passerini P, Cerutti R, Messa P. Urinary mRNA Expression of Glomerular Podocyte Markers in Glomerular Disease and Renal Transplant. Diagnostics (Basel) 2021;11:1499. [PMID: 34441433 DOI: 10.3390/diagnostics11081499] [Reference Citation Analysis]
11 Kim EY, Dryer SE. RAGE and αVβ3-integrin are essential for suPAR signaling in podocytes. Biochim Biophys Acta Mol Basis Dis 2021;1867:166186. [PMID: 34166766 DOI: 10.1016/j.bbadis.2021.166186] [Reference Citation Analysis]
12 Khayyat NH, Tomilin VN, Zaika O, Pochynyuk O. Polymodal roles of TRPC3 channel in the kidney. Channels (Austin) 2020;14:257-67. [PMID: 32787494 DOI: 10.1080/19336950.2020.1804153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shalygin A, Shuyskiy LS, Bohovyk R, Palygin O, Staruschenko A, Kaznacheyeva E. Cytoskeleton Rearrangements Modulate TRPC6 Channel Activity in Podocytes. Int J Mol Sci 2021;22:4396. [PMID: 33922367 DOI: 10.3390/ijms22094396] [Reference Citation Analysis]
14 Sabnis RW. Novel Pyridazinones as TRPC5 Inhibitors for Treating Kidney Diseases. ACS Med Chem Lett 2021;12:526-7. [PMID: 33859787 DOI: 10.1021/acsmedchemlett.1c00123] [Reference Citation Analysis]
15 Gao YY, Tian W, Zhang HN, Sun Y, Meng JR, Cao W, Li XQ. Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials. Arch Pharm Res 2021;44:354-77. [PMID: 33763843 DOI: 10.1007/s12272-021-01319-5] [Reference Citation Analysis]
16 Sabnis RW. Novel Benzimidazole Derivatives as Transient Receptor Potential Channel 6 (TRPC6) Inhibitors. ACS Med Chem Lett 2021;12:314-5. [PMID: 33738049 DOI: 10.1021/acsmedchemlett.1c00056] [Reference Citation Analysis]
17 Chaudhari S, Mallet RT, Shotorbani PY, Tao Y, Ma R. Store-operated calcium entry: Pivotal roles in renal physiology and pathophysiology. Exp Biol Med (Maywood) 2021;246:305-16. [PMID: 33249888 DOI: 10.1177/1535370220975207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Golosova D, Palygin O, Bohovyk R, Klemens CA, Levchenko V, Spires DR, Isaeva E, El-Meanawy A, Staruschenko A. Role of opioid signaling in kidney damage during the development of salt-induced hypertension. Life Sci Alliance 2020;3:e202000853. [PMID: 33046522 DOI: 10.26508/lsa.202000853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Gu LF, Ge HT, Zhao L, Wang YJ, Zhang F, Tang HT, Cao ZY, Yu BY, Chai CZ. Huangkui Capsule Ameliorates Renal Fibrosis in a Unilateral Ureteral Obstruction Mouse Model Through TRPC6 Dependent Signaling Pathways. Front Pharmacol 2020;11:996. [PMID: 32719603 DOI: 10.3389/fphar.2020.00996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Blaine J, Dylewski J. Regulation of the Actin Cytoskeleton in Podocytes. Cells 2020;9:E1700. [PMID: 32708597 DOI: 10.3390/cells9071700] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
21 Wang Q, Tian X, Wang Y, Wang Y, Li J, Zhao T, Li P. Role of Transient Receptor Potential Canonical Channel 6 (TRPC6) in Diabetic Kidney Disease by Regulating Podocyte Actin Cytoskeleton Rearrangement. J Diabetes Res 2020;2020:6897390. [PMID: 31998809 DOI: 10.1155/2020/6897390] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
22 Hall G, Wang L, Spurney RF. TRPC Channels in Proteinuric Kidney Diseases. Cells 2019;9:E44. [PMID: 31877991 DOI: 10.3390/cells9010044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
23 Hassanzadeh Khayyat N, Kim EY, Dryer SE. TRPC6 inactivation does not protect against diabetic kidney disease in streptozotocin (STZ)-treated Sprague-Dawley rats. FASEB Bioadv 2019;1:773-82. [PMID: 32123821 DOI: 10.1096/fba.2019-00077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Pablo JL, Greka A. Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases. Trends Pharmacol Sci 2019;40:911-8. [PMID: 31704171 DOI: 10.1016/j.tips.2019.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
25 Otalora L, Chavez E, Watford D, Tueros L, Correa M, Nair V, Ruiz P, Wahl P, Eddy S, Martini S, Kretzler M, Burke GW 3rd, Fornoni A, Merscher S. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis. PLoS One 2019;14:e0222948. [PMID: 31581251 DOI: 10.1371/journal.pone.0222948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
26 Cassis P, Zoja C, Perico L, Remuzzi G. A preclinical overview of emerging therapeutic targets for glomerular diseases. Expert Opin Ther Targets 2019;23:593-606. [PMID: 31150308 DOI: 10.1080/14728222.2019.1626827] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
27 Staruschenko A, Spires D, Palygin O. Role of TRPC6 in Progression of Diabetic Kidney Disease. Curr Hypertens Rep 2019;21:48. [PMID: 31115705 DOI: 10.1007/s11906-019-0960-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]